Infection Outcomes in Solid Organ Transplant Recipients Receiving Trimethoprim-Sulfamethoxazole as Opposed to Atovaquone for Prophylaxis.

被引:0
|
作者
Drelick, A. [1 ]
Mowrey, W. [2 ]
Minamoto, G. [3 ,4 ]
机构
[1] Weill Cornell Med Ctr, Div Infect Dis, Med, New York, NY USA
[2] Albert Einstein Coll Med, Epidemiol & Populat Hlth, Bronx, NY 10467 USA
[3] Montefiore Med Ctr, Div Infect Dis, Med, 111 E 210th St, Bronx, NY 10467 USA
[4] Albert Einstein Coll Med, Bronx, NY 10467 USA
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
C347
引用
收藏
页码:887 / 887
页数:1
相关论文
共 50 条
  • [31] Trimethoprim-sulfamethoxazole significantly reduces the risk of nocardiosis in solid organ transplant recipients: systematic review and individual patient data meta-analysis
    Passerini, Matteo
    Nayfeh, Tarek
    Yetmar, Zachary A.
    Coussement, Julien
    Goodlet, Kellie J.
    Lebeaux, David
    Gori, Andrea
    Mahmood, Maryam
    Temesgen, Zelalem
    Murad, Mohammad H.
    CLINICAL MICROBIOLOGY AND INFECTION, 2024, 30 (02) : 170 - 177
  • [32] INFECTION PROPHYLAXIS IN ACUTE-LEUKEMIA - A COMPARISON OF CIPROFLOXACIN WITH TRIMETHOPRIM-SULFAMETHOXAZOLE AND COLISTIN
    DEKKER, AW
    ROZENBERGARSKA, M
    VERHOEF, J
    ANNALS OF INTERNAL MEDICINE, 1987, 106 (01) : 7 - 12
  • [33] Orally Administered Trimethoprim-Sulfamethoxazole and Metronidazole as Infection Prophylaxis in Elective Colorectal Surgery
    Hjalmarsson, Claes
    Karlberg, Jonas
    Tornqvist, Pelle
    Arbman, Gunnar
    Frisk, Bjorn
    Modin, Marina
    SURGICAL INFECTIONS, 2015, 16 (05) : 604 - 610
  • [34] INFECTION PROPHYLAXIS DURING GRANULOCYTOPENIA - COMPARISON OF TRIMETHOPRIM-SULFAMETHOXAZOLE TO NALIDIXIC-ACID
    WADE, J
    DEJONGH, C
    SCHIMPFF, S
    NEWMAN, K
    WIERNIK, P
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 417 - 417
  • [35] Therapeutic Drug Monitoring in Lung Transplant Recipients Receiving Itraconazole Prophylaxis.
    Chong, P.
    Hathcock, M.
    Kremers, W.
    Kennedy, C.
    Razonable, R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 806 - 806
  • [36] Duration of prophylaxis with trimethoprim–sulfamethoxazole in patients undergoing solid organ transplantation
    P. Malhotra
    S. D. Rai
    D. Hirschwerk
    Infection, 2012, 40 : 473 - 475
  • [37] Cytomegalovirus infection in pediatric solid organ transplant recipients and role of prophylaxis
    Nance, Gwen
    Serluco, Anastacia
    Deshpande, Shri
    Garro, Rouba
    George, Roshan
    Kelleman, Michael
    Yildrim, Inci
    Liverman, Rochelle
    PEDIATRIC TRANSPLANTATION, 2019, 23
  • [38] Cost of prophylaxis in the management of cytomegalovirus infection in solid organ transplant recipients
    Oppenheimer, Federico
    Gonzalez-Molina, Miguel
    Rubio, Marta
    CLINICAL TRANSPLANTATION, 2007, 21 (04) : 441 - 448
  • [39] Severe hyperkalemia in two renal transplant recipients treated with standard dose of trimethoprim-sulfamethoxazole
    Koç, M
    Bihorac, A
    Özener, ÇI
    Kantarci, G
    Akoglu, E
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 36 (03)
  • [40] Impact of Increased Duration of Trimethoprim-Sulfamethoxazole Prophylaxis for Pneumocystis Pneumonia After Renal Transplant
    Chapman, Fiona A.
    Dickerson, Jonathan E.
    Daly, Conal
    Clancy, Marc
    Geddes, Colin
    ANNALS OF TRANSPLANTATION, 2019, 24 : 625 - 630